Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Growth Hormone-Secreting Pituitary Adenoma × lanreotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 4 Serotonin Syndrome 2 Carcinoid Tumor 2 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors in Lung 1 Intestinal Obstruction 1 Growth Hormone-Secreting Pituitary Adenoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Flushing 1 Endocrine Tumors 1 Diarrhea 1 Carcinoma 1 Carcinoid Heart Disease 1 Adenoma, Islet Cell 1 Acromegaly 1

Interventions

lanreotide 1 Solutions 1 Radiosurgery 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03439709 2018-03-01

MERGE

Samsung Medical Center

Phase 3 Unknown

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡